Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Discover ways to improve ROI on investments. Implement effective strategies to enhance your financial returns and investment success.
16,862 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Royal Caribbean deploys AI to forecast demand, trim waste, and tailor guest experiences, signaling a data-driven shif...
Axsome's 2025 earnings season is shaping up as a pivotal moment for investors. This article breaks down what to expec...
Uber pivots from ride-hailing to a broader mobility and logistics platform, fueling a varied set of 2026–2030 price s...
As Root releases its 2025 earnings, investors want answers beyond a single number. This guide breaks down the key dri...
A vivid look at the origins of Amazon’s empire and the investors who struck it rich long ago. Learn the core moves th...
Chasing Nvidia’s AI-driven rally is tempting, but utility stocks offer stable dividends, growth through grid moderniz...
Amazon has faced headwinds and briefly dipped below $200. This guide explains how to evaluate a dip, set targets, and...
This in-depth analysis digs into the drivers behind foods (bgs) 2025 earnings, exploring brand momentum, debt, and th...
This article breaks down pattern group (ptrn) 2025 earnings with a clear view of what to watch in the quarterly trans...
A noted tech investor forecasts AI could automate most jobs by 2030. This report explores how families might keep ess...
Compass Point flags three financials fresh ratings: wall on UWMC, RKT, and SLRC as rates ease and lending activity is...